jRCT ロゴ

臨床研究等提出・公開システム

Top

Japanese

Mar. 26, 2019

April. 08, 2026

jRCTs021180040

The usefulness of GHRP-2 test in patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma (GHRP-2_pituitary)

The usefulness of GHRP-2 test in patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma (GHRP-2_pituitary)

Murasawa Shingo

Hirosaki University Graduate School of Medicine

5 Zaifu-cho, Hirosaki, Aomori, Japan

+81-172-39-5062

murashin@hirosaki-u.ac.jp

Murasawa Shingo

Hirosaki University Graduate School of Medicine

5 Zaifu-cho, Hirosaki, Aomori, Japan

+81-172-39-5062

murashin@hirosaki-u.ac.jp

Recruiting

Dec. 01, 2017

May. 31, 2019
55

Interventional

single arm study

open(masking not used)

no treatment control/standard of care control

single assignment

diagnostic purpose

patients with thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

Allergy to GHRP-2

15age old over
No limit

Both

thyrotropin-producing pituitary adenoma, acromegaly and prolactinoma

administration of GHRP-2

Serum TSH, GH and prolactin levels after administration of GHRP-2

none

Hirosaki University General Certified Review Board
1 Bunkyo-cho, Hirosaki city, Aomori

+81-172-39-5362

crb-hirosaki@hirosaki-u.ac.jp
Approval

Feb. 27, 2019

none

History of Changes

No Publication date
9 April. 08, 2026 (this page) Changes
8 July. 11, 2025 Detail Changes
7 May. 01, 2024 Detail Changes
6 April. 11, 2024 Detail Changes
5 Aug. 02, 2021 Detail Changes
4 Mar. 17, 2021 Detail Changes
3 Nov. 12, 2019 Detail Changes
2 April. 05, 2019 Detail Changes
1 Mar. 26, 2019 Detail